Mahmut Aslan

Dr. Mahmut Aslan


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2021 in Cureus
Verified
Journal Article
Open access
MAMahmut Aslan
Mahmut Aslan
Febrile seizure (FS) is the most common cause of convulsion in children. In the present study, we evaluated patients presenting with FS. Eighty-two patients aged between 6-60 months who presented to Mersin City Training and Research Hospital with the first febrile seizure between January 2020 and May 2021 were included in the study. Of the 82 patients included in our study, 42 (51,2%) were male and 40 were female (48,8%). Their average age at presentation of first febrile seizure was 21,05 ± 16,22 months. Fever focus was found in 32 patients (39,1%) with upper respiratory tract infection. Epileptic abnormality was observed in the EEG of six patients (7,3%) and antiepileptic medication was started in three of these patients. Upper respiratory tract infection, family history of FS, and family history of epilepsy are the main risk factors for the development of FS. Complex FS is a serious risk factor for the development of epilepsy.

7 June 2022 in Cureus
Verified
Journal Article
Open access
MAMahmut Aslan
Mahmut Aslan
SGSerdal Gungor
Serdal Gungor
Objective: Epilepsy is a condition in which abnormal, recurring, and excessive neuronal discharges caused by many different disorders in the central nervous system are observed. The rate of detecting epileptiform activity in the first interictal electroencephalography (EEG) of patients with epilepsy is around 40%, even when routine activation methods are applied. Video recordings simultaneously with EEG recordings enable the establishment of correlations between abnormalities. Patients and methods: The long-term video-EEG monitoring (VEM) reports and images of 87 patients hospitalized in the video EEG service in the Pediatric Neurology Clinic of İnönü University between 2016 and 2020 were retrospectively analyzed in this study. Demographic information of the patients, such as age, gender, diagnosis/history, and length of hospital stay, was analyzed. Results: A total of 87 patients were included in the study. Of the patients, 54 (62.1%) were male and 33 (37.9%) were female. The mean age was 107.57 ± 64.40 months. While 10 (11.5%) patients followed up with non-epileptic paroxysmal events (NEPE) were taking antiepileptic drugs (AEDs), AED treatments were discontinued after VEM. The diagnosis of 18 (20.69%) patients changed after VEM. The medications of 27 (31%) patients who took AEDs before VEM were discontinued after VEM. During VEM, sleep movement, psychogenic seizures, infantile masturbation, and tic disorder were observed in 19 (41.3%), 17 (36.9%), three (6.5%), and three (6.5%) patients, respectively. Conclusion: In conclusion, VEM is the gold standard diagnostic method used to distinguish between epilepsy and NEPEs. After VEM, the clinical diagnosis of patients can change, and unnecessary drug administration may be prevented. Psychogenic nonepileptic seizures and NEPEs are common in the pediatric population; however, they are often overlooked.

1 January 2020 in Journal of Pediatric Neurosciences
Verified
Journal Article
Open access
PDF file
MAMahmut Aslan
Mahmut Aslan
BOBilge Ozgor
Bilge Ozgor
SKSerkan Kirik
Serkan Kirik
SGSerdal Gungor
Serdal Gungor
Introduction: Dravet syndrome (DS) is characterized by severe infant-onset myoclonic epilepsy with delayed psychomotor development and increased premature mortality. The seizures triggered by fire have been gradually decreased over time, and finally they start to occur without fever at the age of 2–3 years. Along with its initiation of myoclonic seizures in the early period, other types such as atypical absence, versive, and complex partial seizures occur between 1 and 4 years of age. Case Report: A 3-year-old male patient with refractory epilepsy and neuromotor developmental retardation was admitted to our clinic. The patient initially had seizures in the afebrile period, when he was 4 months old, and he had a total of five seizures by the age of 1 year. Neuromotor developmental retardation developed over time in patients with normal neuromotor development in the early stages of his life. His cranial magnetic resonance imaging and metabolic test findings were normal. The SCN1A mutation was investigated, and a new variant mutation of SCN1A, homozygous (p.Y1599Ffs*19-c.4796delA) was detected. The patient’s family was also screened and this new mutation was detected as heterozygous mutation. The patient had hepatomegaly. The etiology of hepatomegaly was investigated but no cause was found. Conclusion: Variant mutations of DS should be kept in mind and diagnostic genetic testing should be done in patients with neuromotor developmental retardation starting with afebrile seizures. In DS, hepatomegaly is not an expected condition. Maybe this new mutation might have caused hepatomegaly.

27 January 2022 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
MAMahmut Aslan
Mahmut Aslan
SGSerdal Gungor
Serdal Gungor

27 July 2018 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
MAMahmut Aslan
Mahmut Aslan
SKSerkan Kirik
Serkan Kirik
BÖBilge Özgör
Bilge Özgör
SGSerdal Güngör
Serdal Güngör
Background Metachromatic leukodystrophy (MLD) is an autosomal recessively (AR) inherited disease caused by the deficiency of the enzyme arylsulfatase A (ARSA). Although MLD is the most common form of hereditary leukoencephalopathy, it is still very rare. More than 200 gene mutations have been identified in the ARSA gene. The most frequently identified mutation is the one located on chromosome 22q13.33. In the present study, new mutations are reported in two siblings of different ages and with different clinical presentations. Case presentation A 9-year-old male patient, suffering from ataxia, attention deficit and perceptual difficulties, was first seen at the age of 7. While the findings of neurological examination and neuroradiological evaluation suggested MLD, the ARSA enzyme levels were analyzed and found to be at a lower limit. Genetic analysis revealed variant homozygous mutations of the ARSA gene at p.N352S/c.1055T>C in exon 6 and at p.E331K/c.991G>A in exon 7. In the genetic analysis of his three siblings and parents, a variant heterozygous mutation of the ARSA gene was detected at p.N352S/c.1055T>C in exon 6 and at p.E331K/c.991G>A in exon 7. Conclusions MLD is a rare disease; however, it is likely to find different variant forms in our population, in which the frequency of consanguineous marriages is high. Genetic diagnosis is important in symptomatic cases with enzyme levels within the normal ranges.

1 December 2019 in Ortadoğu Tıp Dergisi
Verified
Journal Article
Open access
MAMahmut Aslan
Mahmut Aslan
SKSerkan Kırık
Serkan Kırık
BÖBilge Özgör
Bilge Özgör
NANeslihan Aslan
Neslihan Aslan
SGSerdal Güngör
Serdal Güngör